David Parry works as a Venture Partner at Samsara BioCapital. The firm's known portfolio counts 10 companies.
Is David Parry a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Venture Partner at Samsara BioCapital, whose known portfolio counts 10 companies
- Parabilis Medicines
- EpiBiologics
- Ambrosia Biosciences
- Sutro Biopharma
- Kalaris Therapeutics
- Sidewinder Therapeutics
- Coultreon Biopharma
- Link Cell Therapies
- Primmune Therapeutics
- Psivant Therapeutics
Investor Profile
David Parry is listed against sector Healthcare, and focus areas Biotech, Cell Therapy, Drug Discovery and Genomics in the database.
Stage-wise, the deals at Samsara BioCapital cluster around Growth, Late-Stage and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether David Parry is worth approaching.
Colleagues at Samsara BioCapital
Stephen Shuttleworth
Venture Partner
Bourne End, United Kingdom
Aditya Asokan
Senior Associate
San Francisco, United States
Robert Baffi
President and Founder Baffi Biotech Advisors
Novato, United States
Marcos Milla
Venture Partner
Carlsbad, United States
Abraham Bassan
Investing / Company Building
San Francisco, United States
Mike Dybbs
Partner
Burlingame, United States
Nate Tower
Investor
United States
Srini Akkaraju
Managing General Partner
Burlingame, United States
Gunaretnam Rajagopal
Venture Partner
Lansdale, United States
Mitchell Mutz
Venture Investor
San Francisco, United States
Frequently asked questions
Who is David Parry?
David Parry is a venture capital investor based in Mountain View, California, United States, listed as Venture Partner at Samsara BioCapital. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to David Parry personally.
What does David Parry invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does David Parry invest at?
Samsara BioCapital appears in Growth, Late-Stage and Series A rounds across its known deals, and David Parry is listed there as Venture Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is David Parry listed at?
David Parry is listed as Venture Partner at Samsara BioCapital. 10 other people in the database share a firm with David Parry.
How do I contact David Parry?
A LinkedIn page is on file for David Parry. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal